ADW Capital Presents Theses For PAR Technology, RCI Hospitality And CDON

[Valuewalk premium advertisement ad unit]() [Privacy Policy]() ​ ​[ADW Capital Presents Theses For PAR Technology, RCI Hospitality And CDON](​ Like most other hedge funds, ADW Capital was in the red for the first quarter, returning -27.34%. The S&P 500 was down 4.6% for the first three months of the year, while the Russell 2000 was down 7.53%, and the Russell 2000 Value Index was off by 2.4%. Since its inception in 2011, ADW Capital […] [Read More](​ ​[Don’t Get Gamed By GameStop]()​ GameStop Is No Stock We Want To Own The only thing we can guarantee about the GameStop (NYSE:GME) market is that the wild swings in volatility are not over. While the company may be working hard on improving itself, there is still no fundamental reason to own the stock and Wall Street’s interest is very […] [Read More]()​ ​[The Analysts Reel In Their Targets For NetApp](​ But NetApp Is Still A Buy The analysts are reeling in their targets for NetApp (NASDAQ:NTAP) but the stock is still a buy. At least 5 of the 21 analysts covering the stock have come out in the wake of the FQ4 earnings report and they all include price target reductions. The takeaway from the […] [Read More](​ ​[3 Regional Banks Investors Can Bank On]()​ Regional bank stocks may not get all investors’ blood boiling. But they’re definitely worth a look. After all, it’s a group that outperformed the S&P 500 last year advancing 36%—and down a more modest 10% year-to-date, is doing the same in 2022. Both figures are based on the iShares Dow Jones U.S. Regional Bank ETF. […] [Read More]()​ ​[Crispr Therapeutics Advances 366 Spots To 120th Most Popular With Retail Investors](=)​ Crispr Therapeutics AG (NASDAQ:CRSP) is a Swiss-American gene editing biotech company developing gene-based medicines. The company’s technology targets specific DNA sequences to modify, delete or correct them. The company’s platform focuses primarily on ex-Vivo programs that target sickle cell disease, β-thalassemia and B-cell malignancies. The lead program targeting sickle cell disease and β-thalassemia has entered […] [Read More](=)​ ​[Despite Its Many Benefits, Innovation Is Not Always Embraced]()​ When Sam Walton brought low-cost shopping to millions of American consumers by developing new, more efficient ways to deliver products to market, he had to battle entrenched political interests fighting for locally based retailers. The Battle Over Innovation Today’s battle over innovation, as consumers fuel a new trend toward instant delivery, is more about convenience […] [Read More]()​ ​ [facebook]() [twitter]() [linkedin]() [instagram](=) Copyright 2021 VALUEWALK LLC, All rights reserved. You are receiving this email because you subscribed to this newsletter on [valuewalk.com]() [Unsubscribe]( or the 295 Madison Avenue 12th floor, New York, NY 10117 973-685-6523